Global Alzheimer's Disease Diagnostic Market Size, Status and Forecast 2020-2026
Table of Content
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered: Ranking by Alzheimer's Disease Diagnostic Revenue
- 1.4 Market by Type
- 1.4.1 Global Alzheimer's Disease Diagnostic Market Size Growth Rate by Type: 2020 VS 2026
- 1.4.2 Genetic testing
- 1.4.3 Neurological exam
- 1.4.4 Mini-mental state exam (MMSE)
- 1.4.5 Brain imaging
- 1.4.6 Other
- 1.5 Market by Application
- 1.5.1 Global Alzheimer's Disease Diagnostic Market Share by Application: 2020 VS 2026
- 1.5.2 Clinics
- 1.5.3 Hospitals
- 1.5.4 Diagnostic Centers
- 1.5.5 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Global Alzheimer's Disease Diagnostic Market Perspective (2015-2026)
- 2.2 Global Alzheimer's Disease Diagnostic Growth Trends by Regions
- 2.2.1 Alzheimer's Disease Diagnostic Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 Alzheimer's Disease Diagnostic Historic Market Share by Regions (2015-2020)
- 2.2.3 Alzheimer's Disease Diagnostic Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
- 2.3.5 Alzheimer's Disease Diagnostic Market Growth Strategy
- 2.3.6 Primary Interviews with Key Alzheimer's Disease Diagnostic Players (Opinion Leaders)
3 Competition Landscape by Key Players
- 3.1 Global Top Alzheimer's Disease Diagnostic Players by Market Size
- 3.1.1 Global Top Alzheimer's Disease Diagnostic Players by Revenue (2015-2020)
- 3.1.2 Global Alzheimer's Disease Diagnostic Revenue Market Share by Players (2015-2020)
- 3.1.3 Global Alzheimer's Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.2 Global Alzheimer's Disease Diagnostic Market Concentration Ratio
- 3.2.1 Global Alzheimer's Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
- 3.2.2 Global Top 10 and Top 5 Companies by Alzheimer's Disease Diagnostic Revenue in 2019
- 3.3 Alzheimer's Disease Diagnostic Key Players Head office and Area Served
- 3.4 Key Players Alzheimer's Disease Diagnostic Product Solution and Service
- 3.5 Date of Enter into Alzheimer's Disease Diagnostic Market
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Alzheimer's Disease Diagnostic Historic Market Size by Type (2015-2020)
- 4.2 Global Alzheimer's Disease Diagnostic Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
- 5.1 Global Alzheimer's Disease Diagnostic Market Size by Application (2015-2020)
- 5.2 Global Alzheimer's Disease Diagnostic Forecasted Market Size by Application (2021-2026)
6 North America
- 6.1 North America Alzheimer's Disease Diagnostic Market Size (2015-2020)
- 6.2 Alzheimer's Disease Diagnostic Key Players in North America (2019-2020)
- 6.3 North America Alzheimer's Disease Diagnostic Market Size by Type (2015-2020)
- 6.4 North America Alzheimer's Disease Diagnostic Market Size by Application (2015-2020)
7 Europe
- 7.1 Europe Alzheimer's Disease Diagnostic Market Size (2015-2020)
- 7.2 Alzheimer's Disease Diagnostic Key Players in Europe (2019-2020)
- 7.3 Europe Alzheimer's Disease Diagnostic Market Size by Type (2015-2020)
- 7.4 Europe Alzheimer's Disease Diagnostic Market Size by Application (2015-2020)
8 China
- 8.1 China Alzheimer's Disease Diagnostic Market Size (2015-2020)
- 8.2 Alzheimer's Disease Diagnostic Key Players in China (2019-2020)
- 8.3 China Alzheimer's Disease Diagnostic Market Size by Type (2015-2020)
- 8.4 China Alzheimer's Disease Diagnostic Market Size by Application (2015-2020)
9 Japan
- 9.1 Japan Alzheimer's Disease Diagnostic Market Size (2015-2020)
- 9.2 Alzheimer's Disease Diagnostic Key Players in Japan (2019-2020)
- 9.3 Japan Alzheimer's Disease Diagnostic Market Size by Type (2015-2020)
- 9.4 Japan Alzheimer's Disease Diagnostic Market Size by Application (2015-2020)
10 Southeast Asia
- 10.1 Southeast Asia Alzheimer's Disease Diagnostic Market Size (2015-2020)
- 10.2 Alzheimer's Disease Diagnostic Key Players in Southeast Asia (2019-2020)
- 10.3 Southeast Asia Alzheimer's Disease Diagnostic Market Size by Type (2015-2020)
- 10.4 Southeast Asia Alzheimer's Disease Diagnostic Market Size by Application (2015-2020)
11 India
- 11.1 India Alzheimer's Disease Diagnostic Market Size (2015-2020)
- 11.2 Alzheimer's Disease Diagnostic Key Players in India (2019-2020)
- 11.3 India Alzheimer's Disease Diagnostic Market Size by Type (2015-2020)
- 11.4 India Alzheimer's Disease Diagnostic Market Size by Application (2015-2020)
12 Central & South America
- 12.1 Central & South America Alzheimer's Disease Diagnostic Market Size (2015-2020)
- 12.2 Alzheimer's Disease Diagnostic Key Players in Central & South America (2019-2020)
- 12.3 Central & South America Alzheimer's Disease Diagnostic Market Size by Type (2015-2020)
- 12.4 Central & South America Alzheimer's Disease Diagnostic Market Size by Application (2015-2020)
13 Key Players Profiles
- 13.1 Eli Lilly
- 13.1.1 Eli Lilly Company Details
- 13.1.2 Eli Lilly Business Overview
- 13.1.3 Eli Lilly Alzheimer's Disease Diagnostic Introduction
- 13.1.4 Eli Lilly Revenue in Alzheimer's Disease Diagnostic Business (2015-2020))
- 13.1.5 Eli Lilly Recent Development
- 13.2 TauRx
- 13.2.1 TauRx Company Details
- 13.2.2 TauRx Business Overview
- 13.2.3 TauRx Alzheimer's Disease Diagnostic Introduction
- 13.2.4 TauRx Revenue in Alzheimer's Disease Diagnostic Business (2015-2020)
- 13.2.5 TauRx Recent Development
- 13.3 Alector
- 13.3.1 Alector Company Details
- 13.3.2 Alector Business Overview
- 13.3.3 Alector Alzheimer's Disease Diagnostic Introduction
- 13.3.4 Alector Revenue in Alzheimer's Disease Diagnostic Business (2015-2020)
- 13.3.5 Alector Recent Development
- 13.4 Accera
- 13.4.1 Accera Company Details
- 13.4.2 Accera Business Overview
- 13.4.3 Accera Alzheimer's Disease Diagnostic Introduction
- 13.4.4 Accera Revenue in Alzheimer's Disease Diagnostic Business (2015-2020)
- 13.4.5 Accera Recent Development
- 13.5 Treventis
- 13.5.1 Treventis Company Details
- 13.5.2 Treventis Business Overview
- 13.5.3 Treventis Alzheimer's Disease Diagnostic Introduction
- 13.5.4 Treventis Revenue in Alzheimer's Disease Diagnostic Business (2015-2020)
- 13.5.5 Treventis Recent Development
- 13.6 Neuro-Bio
- 13.6.1 Neuro-Bio Company Details
- 13.6.2 Neuro-Bio Business Overview
- 13.6.3 Neuro-Bio Alzheimer's Disease Diagnostic Introduction
- 13.6.4 Neuro-Bio Revenue in Alzheimer's Disease Diagnostic Business (2015-2020)
- 13.6.5 Neuro-Bio Recent Development
- 13.7 Cognition Therapeutics
- 13.7.1 Cognition Therapeutics Company Details
- 13.7.2 Cognition Therapeutics Business Overview
- 13.7.3 Cognition Therapeutics Alzheimer's Disease Diagnostic Introduction
- 13.7.4 Cognition Therapeutics Revenue in Alzheimer's Disease Diagnostic Business (2015-2020)
- 13.7.5 Cognition Therapeutics Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Disclaimer
Description
Alzheimer's Disease Diagnostic market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Alzheimer's Disease Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Eli Lilly
TauRx
Alector
Accera
Treventis
Neuro-Bio
Cognition Therapeutics
...
Market segment by Type, the product can be split into
Genetic testing
Neurological exam
Mini-mental state exam (MMSE)
Brain imaging
Other
Market segment by Application, split into
Clinics
Hospitals
Diagnostic Centers
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America